The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
Last trade$6.71
Day change+$0.05 (+0.75%)
Day range$6.62 – $6.93
Volume51,642
Market cap$91M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$91.17M
Price / earnings
32.26×
Price / book
7.45×
Price / sales
1.55×
EV / sales
1.25×
EV / EBITDA
16.94×
Profitability
Earnings per share
$0.21
Return on assets
6.94%
Return on equity
23.08%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.06×
Current ratio
3.44×
Quick ratio
3.44×
Cash ratio
1.91×
Cash flow
Price / cash flow
26.16×
Price / free cash flow
40.26×
Free cash flow
$2.26M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for JYNT, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$13.55M
$15.18M
$14.82M
$15.17M
$13.38M
$13.27M
$13.08M
$14.71M
Cost of revenue
$2.4M
$2.48M
$2.72M
$2.82M
$2.66M
$2.77M
$2.97M
$3.18M
Gross profit
$11.15M
$12.7M
$12.1M
$12.35M
$10.72M
$10.5M
$10.11M
$11.53M
Selling, general and administrative
$9.56M
$12.44M
$10.8M
$11.17M
$10.11M
$11.23M
$10.42M
$10.3M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$9.82M
$12.87M
$11.22M
$11.6M
$10.56M
$11.63M
$10.78M
$10.65M
Operating income
$1.33M
-$160.56K
$873.67K
$750.31K
$160.92K
-$1.13M
-$678.53K
$875.74K
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
$1.47M
-$242.22K
$1.11M
$940.64K
$300.72K
-$978.25K
-$492.62K
$889.45K
Income taxes
-$10.13K
$9.11K
$11.11K
-$299.73K
$109.98K
$11.39K
$13.4K
-$414.23K
Net income
-$117.36K
$653.02K
$1.3M
$991.1K
$855.01K
$93.36K
$967.8K
$17.67K
Net income attributable to common shareholders
-$117.36K
$653.02K
$1.3M
$991.1K
$855.01K
$93.36K
$967.8K
$17.67K
EBITDA
$1.59M
$263.99K
$1.3M
$1.19M
$623.96K
-$714.31K
-$288.25K
$1.43M
Basic earnings per share
-$0.01
$0.05
$0.09
$0.07
$0.06
$0.01
$0.06
$0.00
Diluted earnings per share
-$0.01
$0.05
$0.09
$0.07
$0.06
$0.01
$0.06
$0.00
Recent news
Company coverage with links to the original publishers.
The Joint Corp. (JYNT) reported Q3 2026 earnings of $0.10 per share, missing the consensus estimate of $0.11 and delivering a -9.09% earnings surprise. Revenue of $13.55 million also fell short of expectations by 7.94%. Despite underperformance, the stock maintains a Zacks Rank #2 (Buy) rating based on favorable estimate revision trends ahead of the earnings release. The Medical - HMOs industry ranks in the top 12% of Zacks industries.
Humana shares surged 11.6% to $431.87, driven by strong Medicare membership growth (up 20.7% YoY to 17.9 million members) and expansion of its CenterWell platform. However, the stock faces headwinds as consensus EPS estimates have been revised 2.7% lower over the past 30 days, and the company is expected to report a quarterly loss of $1.04 per share. The stock holds a Zacks Rank #3 (Hold) rating.
The Joint Corp. signed an Asset Purchase Agreement to sell 22 corporate-owned clinics in the Southeast for $1.5 million to three buying groups, and delivered a notice to terminate a previous agreement for 45 clinics in California.
The Joint Corp. announced plans to restate its 2024 and Q1 2025 financial statements due to overestimated noncash impairment charges, expecting to reduce net loss by $2.2 million and increase net income by $0.5 million.
The Joint Chiropractic has been named the top franchise in chiropractic services by Entrepreneur Magazine's Franchise 500, jumping 29 spots to rank No. 54 on the 2025 list.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.